Lv3
378 积分 2023-02-06 加入
Multi-Axis Attention With Convolution Parallel Block for Organoid Segmentation
1个月前
已完结
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo- controlled, phase 3 trial
1个月前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Efficacy and Safety Comparison of Regorafenib and Fruquintinib in Metastatic Colorectal Cancer-An Observational Cohort Study in the Real World
2个月前
已完结
Increased survival with enzalutamide in prostate cancer after chemotherapy
6个月前
已完结
Biosensors for the Detection of Bacillus anthracis
6个月前
已完结
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study
8个月前
已完结
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
9个月前
已完结
皖公网安备34019202002308
